Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
Arcus Biosciences, Inc.
Universidade Federal de Pernambuco
Incyte Corporation
Shenzhen BinDeBio Ltd.
M.D. Anderson Cancer Center
Rutgers, The State University of New Jersey
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
AstraZeneca